Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 55% over the last three years
yahoo.com
news
2022-10-18 14:48:15

Coherus BioSciences, Inc. (NASDAQ:CHRS) shareholders should be happy to see the share price up 14% in the last quarter. Meanwhile over the last three years the stock has dropped hard. Indeed, the share price is down a tragic 55% in the last three years. Some might say the recent bounce is to be expected after such a bad drop. After all, could be that the fall was overdone.

Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.
